Psoriasis is a chronic inflammatory immune disease that causes itchy, scaly red patches to develop on the skin. These patches tend to flare up and then go into remission, and although some medications help manage symptoms, many patients continue to experience adverse side effects (1). Psoriasis involves overactivation of TH 17, a type of cell that causes an inflammatory response. This is likely because the cells that suppress TH 17, called T regulatory cells (Tregs), are impaired in people with psoriasis (2, 3). Treatments that can either decrease TH 17 activity or increase Treg function have the potential to reduce the symptoms present in psoriasis (4). Additionally, patients with psoriasis exhibit weakened blood circulation due to decreased availability of nitric oxide (5).
Extivita Therapies for Psoriasis: